VITAMIN A IS AN essential nutrient required for vision, reproduction, cellular growth and differentiation, the immune response, and embryological development (9, 18, 26) . The majority of vitamin A actions are mediated through the binding of its active metabolite, all-transretinoic acid (atRA), to nuclear receptors (4) . Two families of retinoid receptors have been identified, retinoic acid (RA) receptors (RAR-␣, -␤, and -␥) and retinoid X receptors (RXR-␣, -␤, and -␥). RXR binds 9-cis-retinoic acid (9cRA), whereas RAR binds both atRA and 9cRA (2) . Retinoid receptors have been identified in numerous tissues, including liver, kidney, spleen, testis, lung, spinal cord, and brain (4) .
The importance of vitamin A, particularly RA, for the proper development of the central nervous system (CNS) has been well established (4, 14, 28 ). An overabundance and lack of vitamin A cause a number of defects in brain patterning (5, 11) . Aldehyde dehydrogenases that catalyze the formation of RA, retinaldehyde dehydrogenase-1 and -2, have been identified in areas of embryos where the presence of RA is important for proper CNS development (19) . A cytochrome P-450 enzyme, P-450RAI-1, which is capable of catabolizing RA into polar derivatives, has been identified in areas of embryos that are highly sensitive to the teratogenic actions of RA (1) .
The conversion of retinol (ROL) to RA and the function of RA have not been well established in the adult CNS. RA is synthesized in crude adult rabbit brain homogenates (8) and was detected in specific areas in the brain of songbirds (6) , suggesting that RA is not only required for the proper development of the CNS but continues to play a role in the adult CNS as well. Biochemical apparati, such as retinoid receptors and cellular retinoid-binding proteins, that are required for retinoid signaling are present in adult brain (4, 17, 31) . Impaired dopamine signaling and impaired locomotion were observed in mutant mice in which a combination of RAR-␤ and RXR-␤ or -␥ was ablated, suggesting a possible function for RA in the adult mouse brain (12) . A novel cytochrome P-450 enzyme, P-450RAI-2, was detected in adult brain, primarily in the cerebellum (29) , which may play an essential role in regulating RA levels in the adult brain.
In this study, RA was detected throughout the brain and in the spinal cord or vitamin A-deficient (VAD) rats treated with 1 g or 3.52 nmol all-trans-retinol (atROL), an amount of atROL required for a biological response. RA comprises a greater proportion of the retinoid pool in the CNS compared with other target tissues (27) . The relatively high levels of RA present in the brains of these rats is not the result of preferential transport of RA from the blood to the brain. Although we show that RA enters the brain, the levels of RA transported to the liver, testis, and spleen were higher than those observed for the brain 10 h after an injection of atRA. Because RA is not transported preferentially to the brain, it seems more likely that RA is synthesized more efficiently in the tissues of the CNS compared with other target tissues.
METHODS

Metabolism of atROL.
Weanling (21-day-old) male Sprague-Dawley rats were maintained on a purified VAD diet. After 4 wk, rats were weighed. On average, the rats weighed ϳ250 g. Weights were monitored until a weight-gain plateau and subsequent loss of ϳ20 g body wt were observed, indicating vitamin A deficiency. Four rats were injected intrajugularly with 250 Ci (1 g, 3.53 nmol) of [20- 3 H]atROL (NEN), 95% purity, in 100 l ethanol. Ten hours after treatment, animals were killed. Brains were removed, and the brain stem, cerebellum, and the hippocampus along with cortex were isolated. The spinal cord was also harvested from the four animals.
Extraction. The brain stem, cerebellum, hippocampus, cortex, remaining brain tissue, and spinal cord were weighed, minced, and homogenized in degassed, deionized water (1 ml/g tissue) containing 0.15% n-propyl gallate (Sigma) with a Teflon homogenizer (Wheaton).
Extraction of the homogenates was performed using a modified version of the Bligh and Dyer method for lipid extraction (13) . Degassed methanol (Burdick and Jackson; Muskegon, MI) containing 0.1% butylated hydroxytoluene (BHT; Sigma) and degassed methylene chloride (Burdick and Jackson) containing 0.1% BHT (Sigma) were added to the homogenized tissue to give a 1:2:1 water-methanol-methylene chloride ratio. Tissue was extracted for 2 h at 4°C using an extraction wheel. Samples were centrifuged at 3,200 g for 7 min using a Beckman Accuspin FR centrifuge. Supernatant was decanted, and the tissue debris was resuspended in a 1:2:1 water-methanol-methylene chloride mixture. The tissue pellet was extracted overnight at 4°C using an extraction wheel.
Samples were centrifuged as before, and the supernatants from the washes were pooled with the initial extracts. Water and methylene chloride were added to the supernatants to give a 1:1:1 ratio of water-methanol-methylene chloride. The organic and aqueous fractions were separated, and the organic extract was dried under N2. Samples were dissolved in 900 l of column solvent for HPLC analysis.
Control experiments were performed by harvesting brains from VAD rats that were not injected with radiolabeled ROL. Tissues were homogenized and boiled. The boiled homogenate was incubated on ice in the presence of degassed methanol and methylene chloride, both containing 0.1% BHT. [20- 3 H]atROL (NEN), 90% pure, 1 Ci (60 Ci/nmol) or [20- 3 H]atRA (NEN), 92% pure, 1 Ci (60 Ci/nmol) was added to the homogenate. The extraction procedure was performed as described above.
HPLC. All HPLC was performed using a Waters 600 pump and controller attached to a Waters 996 photodiode array detector. A Foxy 200 fraction collector (Isco) was used to collect fractions. Data were analyzed using Waters Millenium software. All solvents used in HPLC analysis were purchased from Burdick and Jackson. Nonradiolabeled atROL (Spectrum) and atRA (Spectrum), 1 g of each, were added to all samples before HPLC analysis. Organic extracts were analyzed using a 250 ϫ 4.6-mm, 7-m, Zorbax silica column (Phenomenex). The normal-phase HPLC method was adapted from Meyer et al. (20) . A step gradient of solvent A [hexane-isopropyl alcohol-acetic acid (200:0.5:0.5)] and solvent B (isopropyl alcohol containing 0.25% acetic acid) was used. The exact gradient is shown in Figs. 1 and 2 .
Reverse-phase HPLC was performed on the putative ROL and RA compounds collected after normal-phase HPLC. This method was similar to the one reported by Motto et al. (22) . A 250 ϫ 4.6-mm Zorbax octadecyl silane (ODS) column (Phenomenex) was used as the stationary phase. A mixture of 30% acetonitrile, 25% methanol, 15% isopropyl alcohol, and 30% water [all containing 1.2% (vol/vol) acetic acid] was used as the mobile phase. Putative ROL compounds from normalphase HPLC were quantitated using an isocratic reverse phase system based on a method by MacCrehan and Schonberger (16) . A 250 ϫ 4.6-mm Develosil ODS-HG-5 column (Phenomenex) was used as the stationary phase. A mixture of 60% methanol, 10% n-butanol, and 30% water containing 10 mM ammonium acetate (Mallinkrodt, AR) was used as the mobile phase.
RA transport experiment. Ten-week-old VAD male Sprague-Dawley rats were maintained on a purified diet free of vitamin A containing 12 g RA/g diet while the experimental methodology was developed. Approximately 10 days before the experiment, the animals were fed a purified diet free of RA. Weights of the animals were monitored until a weightgain plateau and subsequent loss of ϳ20 g body wt were observed, indicating retinoid deficiency. Once all animals displayed signs of vitamin A deficiency, loss of weight, and xerophthalmia, the rats were injected intrajugularly with 0.6 g (116 Ci) of H]atRA, 93% pure (NEN), in 100 l ethanol. Nine hours after RA injection, 1.5 mg (1.5 Ci) of [ 14 C-carboxyl]inulin (Amersham Pharmacia) were injected in 50 l of 0.15 M NaCl through the tail vein of each animal. After 30 min, the animals were anesthetized. Blood was collected, and the animals were perfused through the heart with 80 ml PBS. Brain, liver, lung, spleen, and testis were collected. Serum was isolated through centrifugation at 2,800 g for 15 min. Tissues were solubilized using Soluene (Packard). Levels of tritium and carbon-14 were measured using a Tri-Carb 2300TR liquid scintillation counter (Packard).
Statistical analysis. Statistical analysis was performed using the Student's t-test. A P value Ͻ0.05 was considered significant.
RESULTS
RA is found throughout the brain and in the spinal cord and comprises a proportionally higher level of the retinoid pool compared with other target tissues.
VAD rats were treated with 250 Ci (1 g, 3.52 nmol) of atROL. The brain and spinal cord were harvested 10 h posttreatment. The brain was dissected into the following four sections: hippocampus-cortex, cerebellum, brain stem, and remaining brain matter. Radiolabeled retinoids were extracted from the tissue and were analyzed using normal-phase HPLC. The chromatograms of the cerebellum and hippocampus-cortex extracts from one of the four rats and the organic extract from the ROL degradation control experiment are shown in Fig. 1 . All areas of brain and spinal cord from the four animals showed similar chromatograms. Three peaks of radioactivity were detected in the organic extracts from the brain and spinal cord. A peak coeluting with RA was observed between 7 and 10 min, a peak coeluting with ROL was observed at 33 min, and the final peak was eluted at 45 min. Because retinoids are extremely labile compounds, control experiments were essential to determine whether the radiolabeled compounds detected upon HPLC analysis were metabolites or degradation products. The degradation control experiments were performed by homogenizing brains harvested from VAD rats not injected with [20- 3 H]atROL. The homogenates were boiled and incubated on ice in the presence of organic solvents to destroy the enzymatic activity responsible for the metabolism of atROL or atRA. Radiolabeled atROL or atRA was added to the boiled homogenates, and extraction and HPLC analysis were performed. Two peaks of radioactivity were observed in the ROL degradation control experiment, one coeluting with ROL at 33 min and the second at 45 min. Thus RA is not produced through the degradation of ROL during the extraction procedure. Two peaks of radioactivity were observed in the RA degradation experiment, one coeluting with RA at 8 min and the second eluting at 45 min. Reversephase HPLC analysis of the 45-min peak collected from normal-phase HPLC demonstrated that the compounds eluted at 45 min during normal-phase HPLC analysis were degradation products of ROL and/or RA (data not shown).
The putative RA and ROL compounds were collected and reanalyzed using reverse-phase HPLC to confirm their identities. The putative RA coeluted with nonradiolabeled RA at 64 min upon reverse-phase HPLC analysis ( Fig. 2A) . The putative ROL peak was observed at the same retention time, 51 min, as nonradiolabeled ROL (Fig. 2B) . Therefore, RA is the major metabolite of atROL present in the CNS of VAD rats 10 h posttreatment with a physiological amount of atROL.
Quantitation of the radioactivity demonstrated that RA comprised 17.5 Ϯ 1.7, 27.2 Ϯ 2.9, 11.1 Ϯ 0.7, 19.8 Ϯ 1.6, and 23.5 Ϯ 0.8% of the total organic extract from brain stem, hippocampus-cortex, cerebellum, remaining brain matter, and spinal cord, respectively (Table  1) . These levels of RA are relatively higher than the percentages of RA present in the organic extracts of bone (5.95 Ϯ 0.66%), kidney (4.20 Ϯ 0.86%), liver (9.41 Ϯ 1.96%), lung (5.45 Ϯ 0.45%), small intestine (7.24 Ϯ 0.98%), skin (9.75 Ϯ 1.44%), spleen (7.46 Ϯ 0.65%), and testis (2.31 Ϯ 0.66%) of rats injected with 1 g [20-
3 H]atROL, as previously reported (27) . Therefore, RA is not only the major metabolite of atROL in the brain and spinal cord from these VAD rats 10 h postinjection of a physiological amount of atROL; RA comprises a relatively higher proportion of the retinoid pool in the CNS than in other target tissues. Fig. 1 . Normal-phase HPLC analysis of the organic extracts from the cerebellum (black squares) and hippocampus-cortex (light gray squares) from vitamin A-deficient (VAD) rats injected with 1 g of 3.5 nmol (550,000,000 dpm) [20- 3 H]all-trans (at)-retinol (ROL). Dotted line (broken line) denotes the mobile phase gradient. The remaining brain and spinal cord samples from all 4 rats showed similar chromatograms. Retinol was observed at 33 min in all tissue extracts and in the retinol degradation control (dark gray squares). Retinoic acid (RA) was detected between 5 and 12 min in all tissue extracts but was not observed in the control. The peak eluted at 45 min was present in the control and was not analyzed further. 9cROL, 9-cis-ROL. HRR, 14-hydroxy-retroretinol; DHT, 2-hydroxymethyl-3-methyl-5-(2Ј-oxopropyl)-2,5-dihydrothiophene. Fig. 2 . Reverse-phase HPLC analysis of the putative retinoic acid (A) and retinol (B) peaks collected from normal-phase HPLC of the organic extracts from the cerebellum (black squares) and hippocampus-cortex (gray squares). The chromatograms from these two tissue extracts are representative of the chromatograms collected from the remaining tissue extracts from all 4 rats. Retinoic acid was detected in all putative retinoic acid peaks eluting as the major peak upon reverse-phase HPLC analysis at 64 min (A). The presence of retinol in the tissue extracts was confirmed by detection of a peak of radioactivity eluting at 51 min upon reverse-phase HPLC (B).
The femtomoles of RA per gram tissue were calculated for the entire brain and spinal cord ( Table 2) Table 2 ).
atRA enters the brain from the bloodstream. To determine whether the relatively high levels of RA detected in the brain were the result of preferential transport of circulating RA to the brain, VAD rats were injected with 0.6 g (116 Ci) of [20- 3 H]atRA intrajugularly. Nine hours post-RA injection, the rats were injected through the tail vein with 1.5 mg (1.5 Ci) of [ Because inulin does not cross the blood-brain barrier (20) , detection of inulin in the solubilized brain shows that some blood remains in the tissue after perfusion with PBS. Therefore, the [ (Table 3) .
atRA is not preferentially transported to the brain compared with other target tissues. Although atRA was transported to the brain from the blood, atRA was also transported to other target tissues through the bloodstream. Liver, testis, spleen, and lung from the VAD rats given [ 3 H]RA and [ 14 C]inulin were solubilized, and inulin and RA were quantitated. Both compounds were detected in the tissues, demonstrating that blood remained in these tissues after perfusion with PBS. Amounts of RA transported to the tissues were calculated as described above for the brain samples. The liver contained the highest amount of RA [8.74 Ϯ 0.38 ng RA (29.1 Ϯ 1.3 pmol)/g tissue (Table 3) ]. The lowest levels of RA were found in the lung [0.61 Ϯ 0.02 ng RA (2.1 Ϯ 0.1 pmol)/g tissue]. The levels of RA in testis and spleen were 2.13 Ϯ 0.25 ng RA (7.1 Ϯ 0.8 pmol)/g tissue and 1.45 Ϯ 0.15 ng RA (4.8 Ϯ 0.5 pmol)/g tissue, respectively (Table 3) . More RA was present in liver, Data represent the average amounts of retinoic acid or retinol/g tissue (means Ϯ SD) from 4 vitamin A-deficient rats injected with 3.52 nmol [20- 3 H]all-trans-retinol. * P Ͻ 0.001, † P Ͻ 0.005, and ‡ P Ͻ 0.01 compared with the amount of retinoic acid detected in the brain. testis, and spleen than was present in the brain 10 h postinjection of atRA. This suggests that either more atRA was transported to the liver, testis, and spleen than to the brain or that the liver, testis, and spleen may clear RA less efficiently than the brain. If the latter was true, it seems unlikely that relatively high levels of RA would be detected in the brains of VAD injected with a physiological amount of atROL, as demonstrated in the initial experiment. Thus RA enters the brain but is not preferentially transported from the blood to the brain compared with other target tissues.
DISCUSSION
Vitamin A is important for the proper formation and patterning of the CNS during embryogenesis (14, 18) . This is especially clear in hindbrain development where embryos from VAD mothers suffer defects in hindbrain patterning (11, 28) . This phenotype can be rescued by treating the mothers with vitamin A or with pharmacological doses of atRA (30), the bioactive metabolite of vitamin A responsible for cellular growth and differentiation. Although RA is essential for embryological development, a teratogenic phenotype similar to the phenotype observed in VAD embryos is also observed in embryos from mothers fed an excess of vitamin A (5). Thus it is imperative that the synthesis and degradation of RA in the developing CNS be tightly regulated. The identification of a retinaldehyde dehydrogenase, RALDH2, and isolation of an RA catabolic enzyme, P-450RAI-1, in embryonic tissues provide a potential mechanism for the regulation of RA levels during development (19, 29) .
The function of RA and conversion of ROL into RA in the adult brain are not well understood. It seems likely that vitamin A plays a role in neurological functions of adult animals, since retinoid-binding proteins have been identified in the adult brain and spinal cord. Both cellular ROL-binding protein and ROL-binding protein have been identified in cells comprising the blood-brain barrier, suggesting a mechanism by which vitamin A may enter the brain (17) . The nuclear retinoid receptors RAR and RXR have been characterized in the adult brain (4). Mice in which the genes encoding RAR-␤-RXR-␤, RAR-␤-RXR-␥, and RXR-␤-RXR-␥ were disrupted showed impaired locomotion (12) . This locomotor defect was not because of abnormalities in the skeletal muscle or peripheral nervous system but was the result of a defect in the dopamine signaling pathway. A putative retinoic acid response element has been characterized in the promoter encoding the D 2 dopamine receptor, providing a possible link between the retinoid signaling pathway and the dopamine signaling pathway (24) . RA is not only required for the development of cultured, nerve growth factor-supported, embryonic chick sympathetic neurons, but RA is essential for the maintenance of neurites (23) . This suggests that RA may play a role in the survival of developed neurites such as those found in the adult CNS. The presence of RA itself in adult brain further supports a physiological role for vitamin A in the adult CNS. RA is produced from ROL in crude adult rabbit brain homogenate (8) and has been detected in brain from adult song birds (6) . These studies suggest that vitamin A exerts its actions on the CNS through the binding of RA to nuclear receptors and subsequent control of gene transcription.
This study demonstrates that RA is not only present throughout the brain and in the spinal cord of adult VAD rats given a physiological (1 g, 3.52 nmol) amount of atROL, but it is detected at levels that are relatively higher than those detected in other target tissues. RA comprised the highest proportion of the organic phase radioactivity in the hippocampus-cortex, and the lowest percentage of RA was detected in the cerebellum. The relatively low levels of RA in the cerebellum compared with other areas of the brain may be because of an abundance of P-450RAI-2, a novel RA-inducible, RA-catabolizing, cytochrome P-450 enzyme found in the adult brain, primarily in the cerebellum (29) . The high expression of this RA-catabolizing enzyme in the cerebellum provides a mechanism for enhanced RA clearance from that area of the brain. The relatively high proportion of RA in the hippocampus-cortex found in this study supports the previous work linking RA and proper motor skills (12) , because motor skills map to areas of the cortex.
The levels of RA detected in the brain are higher than the percentages of RA present in the organic extracts of other target tissues from rats injected with 1 g (3.52 nmol) [20- 3 H]atROL, as we previously reported (27) . Not only is RA detected in relatively higher proportions in the brain, but the femtomoles of RA per gram tissue detected in the brain are relatively high compared with the amounts we previously reported from other target tissues (27) . Only the liver and kidney displayed higher levels of RA than the brain. Both the liver and kidney contain much higher levels of ROL than the brain, so relatively high levels of RA are present in the brain even though there is a relatively low abundance of ROL, the metabolic starting point in the synthesis of RA, in the brain. Thus it seems possible that RA is either synthesized more efficiently in the brain than in other target tissues or is transported preferentially from the blood to the brain. Preferential transport of circulating RA to the brain and spinal cord would result in the relatively high levels of RA observed.
RA circulates through the bloodstream bound to serum albumin at very low levels under normal physiological conditions (7) . Previous work demonstrated that RA is transported to a variety of tissues in VAD rats given small doses of RA (25) . The highest levels of RA were detected in the liver, kidney, and intestine, whereas the lowest levels were detected in the testis and fat pads. The brain was not analyzed in the study. RA is detected in the brain of vitamin A-sufficient rats treated with pharmacological amounts of RA (15) . However, it remained unclear whether RA, given at physiological levels, could enter the brain of VAD rats. Our work demonstrates that RA does enter the brain of VAD adult rats. However, much higher amounts of RA were detected in the liver, spleen, and testis, and similar amounts of RA were detected in the lung compared with the brain, suggesting that RA is not transported preferentially to the brain.
The relatively low amounts of RA transported to the brain of VAD rats given a physiological amount of RA are somewhat unexpected, since a previous study demonstrated that the majority of RA present in the brain and liver is derived from circulating RA, whereas the testis obtains very little RA from the circulation (13) . The aforementioned experiments were performed using vitamin A-sufficient rats that were infused with a continuous amount of [ 3 H]atRA. We used VAD rats given a physiological amount of atRA. Thus it seems that vitamin A status and the amount of RA given to rats may affect tissue-specific transport of RA.
Because RA is not transported preferentially to the brain, it seems likely that the formation of RA from ROL is more efficient in the CNS than in other areas of the body. A number of enzyme(s) responsible that convert atROL to atRA have been identified in various adult, mammalian tissues, including liver, skin, eye, adrenal gland, and reproductive tissue and embryos (10) . However, very little is understood about the metabolic pathway that converts atROL to atRA in the adult CNS. Many of the enzymes credited with the bioactivation of vitamin A lack substrate specificity, and their physiological relevance is unclear (10) .
This work clearly demonstrates that RA is present throughout the brain and spinal cord of adult VAD rats treated with a physiological amount of atROL. Not only is RA detected throughout the brain and spinal cord, it is present at relatively higher levels than in other target tissues, suggesting a vital need for RA in the CNS of VAD adult rats. Although RA can enter the brain, it is not transported preferentially to the brain. Thus it seems likely that RA is synthesized more efficiently in the CNS than in other target tissues. Ultimately, the CNS may be an excellent place to isolate the enzyme(s) comprising the metabolic pathway that converts atROL to atRA.
